Nerve cell discovery may improve neurodegenerative disease treatments

By The Science Advisory Board staff writers

November 16, 2022 -- Researchers at King’s College London and the University of Bath have made a nerve cell discovery that may improve treatment options for patients with neurodegenerative diseases, including Alzheimer’s.

The study, published November 15 in the journal Current Biology, investigated proteins that play an essential role in nerve cell development and cause disease when they malfunction.

Splicing proteins were known to aggregate into insoluble complexes in cell cytoplasm which can interfere with nerve cell function. However, this study found a major splicing protein in the protein/messenger RNA complexes within nerve cell axons. Axon dysfunction often results in progressive neurological disorders.

The scientists found that the splicing protein SNRNP70 binds to, and subsequently shapes, mRNA strands. This mRNA carries genetic information from the cell nucleus to the cytoplasm where it is used to create further proteins.

Using zebrafish, the researchers disrupted the splicing protein's function. Motor neurons then failed to establish normal connections while losing other connections -- behavior also observed in human neurodegeneration.

However, when SNRNP70 was re-introduced into these neurons' cytoplasm and axons, it restored motor connectivity and neuronal function. The researchers believe this splicing protein is essential for mRNA to move from the nerve cell body along axons to peripheral neuron parts.

"Now we know these types of molecules have a function outside the nucleus, we will need to approach neurodegeneration from a different angle, asking ourselves how these disease-causing aggregates interfere with the function of these proteins not only in the nucleus but also in the cytoplasm, and what role they play in the breakdown of neurons. This is something that hasn't been thought about before," co-author Nikolas Nikolaou, PhD, from the University of Bath's Department of Life Sciences, said in a statement.

Nucleolin could be key to understanding neurodegenerative disorders
A new study challenges recent theories of the role structures inside the nucleus play in neurodegenerative disorders and suggests the relevance of researching...
Key molecule may block nerve loss in neurodegenerative diseases: studies
Researchers investigate neurodegenerative disease treatments to target sterile alpha and TIR motif containing 1 (SARM1) -- a molecule that serves as chief...
RNA splicing defects in mouse model sheds light on Alzheimer’s
St. Jude Children’s Research Hospital scientists created a mouse model to study the role of RNA splicing defects in Alzheimer’s disease, revealing degeneration...
HHMI researchers spot new synapse in primary cilia of neurons
There’s a new kind of synapse in the primary cilia of neurons, according to researchers at Howard Hughes Medical Institute’s (HHMI) Janelia Research Campus...
Repurposed drug shows promise in animal studies as potential therapy for ALS
A drug used to treat enlarged prostates and high blood pressure could help to slow the progression of motor neuron disease, which is also known as amyotrophic...
Global consortium creates 'largest' zebrafish genetic atlas to support human disease research
An international consortium of 27 laboratories called DANIO-CODE has created an atlas of genetic data on zebrafish to support research into conditions...

Copyright © 2022 scienceboard.net


Conferences
Cell Bio 2022
December 3-7
District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter